Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : AMERICAN BIOMED, Minimally Invasive Technology (ABMI) -- Ignore unavailable to you. Want to Upgrade?

To: Buendia who wrote (512)	4/19/1998 7:42:00 PM
From: Ray Tarke	Read Replies (1) \| Respond to of 2887

ABMI-Scientific Advisory Board ABMI has managed to assemble an impressive advisory board that contributes years of combined expertise in both the vascular and medical regulatory fields. Some of the medical professionals that have aligned themselves with ABMI include: Michael E. DeBakey, M.D. Samuel S. Ahn, M.D., F.A.C.S. Larry Stuart-Deutsch, M.D. Darwin Eton, M.D., F.A.C.S.. Lawrence A Yeatman, M.D., F.A.C.C. David A. Lee, M.D. J. Patrick Johnson, M.D. Richard Stout, M. It should be easy for the growth oriented investor to see the tremendous upside potential that is represented within American BioMed's stock. The Company has proven to be aggressively pursuing and implementing its strategic business plan. It is focused on a fundamentally sound approach for commercialization of its products and has assembled an experienced management team that includes medical and scientific advisory board members. This team will help direct the growth of the Company well into the future. That will provide a strong foundation from which shareholder value will be increased. ABMI has over twenty-seven patents and patent pendings cover its technologies that compete in a $10 billion annual market. The product lines are state-of-the-art and should capture a growing share of the markets. This Company has the potential to become a Big Winner with or without a buy out in the near future. A recent hiring of Marshall Kerr as sales and marketing as proven that his aggressive.. and will improve revenues signing new distributors, more OEM contracts will add cash to expiate R&D and bringing revolutionary products to the market. Fudamentals improving daily! ABMI will show in the coming months a growing company with more OEM contracts, FDA approval, and quite possibly catch some big boys eye. Lets have a great week !! regards, R.T